PAR-25-039-Full-Announcement.html

This document is a Full Announcement for the federal grant opportunity titled "Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)".

The grant opportunity is sponsored by the Department of Health and Human Services National Institutes of Health and is funded under the Mental Health Research Grants program (CFDA 93.242). The purpose of this initiative is to advance translational research to better understand the emergence and trajectory of schizophrenia and related disorders in mid to late life, and to identity targets for future development of prevention and treatment efforts.

The grant is open to a range of applicant types including city/township governments, nonprofits, higher education institutions, small businesses, and others. The funding instrument is a grant, and the application deadline is not provided. No award amount details are included. Eligible costs and other administrative requirements are not summarized here.